Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Double Blind Dose-Ranging Study to Assess the Safety, Tolerability and Immunogenicity of a Monovalent H5 DNA Influenza Vaccine (A Vietnam/1194/2004) Administered by Particle Mediated Epidermal Delivery (PMED) to Healthy Adults

NCT00347529 is registered in ClinicalTrials.gov with PowderMed as lead sponsor.

NCT NCT00347529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00347529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Double Blind Dose-Ranging Study to Assess the Safety, Tolerability and Immunogenicity of a Monovalent H5 DNA Influenza Vaccine (A Vietnam/1194/2004) Administered by Particle Mediated Epidermal Delivery (PMED) to Healthy Adults
Lead sponsor
PowderMed
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2006
Completion date
January 31, 2007
Enrollment
75
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza (pandemic)